Search results for: 'Sector forecasts'

The study aims to analyse and forecast future trends for the US and European patient monitoring solutions market. The industry is transitioning and the focus of patient monitoring solutions market participants has been evolving significantly. The study provides key market breakdowns, trends, strategies, and challenges impacting the US and European ...

The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By stre...

Attention deficit hyperactivity disorder (ADHD) is one of the most common mental health disorders in childhood and adolescents, and affects an estimated 4.1 percent of adults, ages 18 to 44, in a given year. The adult ADHD market, however, is significantly less penetrated than the pediatric market and has strong potential for growth in the near-ter...

According to the Centers for Medicare and Medicaid Services (CMS), value-based care (VBC) programs reward healthcare providers with incentive payments for the quality of care they provide Medicare patients. These programs are part of its larger CMS quality strategy to reform healthcare delivery and payment. Value-based programs support 3 aims: b...

Cardiology is the second-largest generator of patient image data and reports, which need to be stored/archived, analyzed, and managed. This, coupled with hospitals need to provide timely, high-quality care to patients, given the urgency of cardiology cases, necessitates a holistic view of cardiac patient data and a well-connected, enterprise-wide ...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

This report examines the regulations surrounding digital health in North America and Europe. It provides a general analysis of key national and regional regulatory updates that will impact digital health players and influence market dynamics. The regulatory documents considered are those governing the healthcare sector and applicable to digital hea...

This study analyzes the stroke care continuum, identifying bottlenecks and challenges as well as the opportunities emerging from the changes in the stroke care market. Stroke is one of the major causes of disability and death globally. The high prevalence of stroke and its growing burden on the economy is increasing the importance of stroke care ...

Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as signif...